Annual Drug Patent Expirations for SUBOXONE
Suboxone is a drug marketed by Indivior and is included in two NDAs. It is available from one supplier. There are four patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for SUBOXONE.
This drug has one hundred and eigthy-six patent family members in twenty-six countries.
The generic ingredient in SUBOXONE is buprenorphine hydrochloride; naloxone hydrochloride. One supplier is listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
